Histone Demethylase LSD1 Regulates Bone Mass by Controlling WNT7B and BMP2 Signaling in Osteoblasts

Overview

Journal Bone Res

Specialties Endocrinology
Orthopedics

Date 2018 May 1

PMID 29707403

Citations 29

Authors

Jun Sun

Joerg Ermann

Ningning Niu

Guang Yan

Yang Yang

Yujiang Shi

Weiguo Zou

Affiliations

Soon will be listed here.

Abstract

Multiple regulatory mechanisms control osteoblast differentiation and function to ensure unperturbed skeletal formation and remodeling. In this study we identify histone lysine-specific demethylase 1(LSD1/KDM1A) as a key epigenetic regulator of osteoblast differentiation. Knockdown of LSD1 promoted osteoblast differentiation of human mesenchymal stem cells (hMSCs) in vitro and mice lacking LSD1 in mesenchymal cells displayed increased bone mass secondary to accelerated osteoblast differentiation. Mechanistic in vitro studies revealed that LSD1 epigenetically regulates the expression of WNT7B and BMP2. LSD1 deficiency resulted in increased BMP2 and WNT7B expression in osteoblasts and enhanced bone formation, while downregulation of WNT7B- and BMP2-related signaling using genetic mouse model or small-molecule inhibitors attenuated bone phenotype in vivo. Furthermore, the LSD1 inhibitor tranylcypromine (TCP) could increase bone mass in mice. These data identify LSD1 as a novel regulator of osteoblast activity and suggest LSD1 inhibition as a potential therapeutic target for treatment of osteoporosis.

Citing Articles

The multifaceted role of post-translational modifications of LSD1 in cellular processes and disease pathogenesis.

Li Y, Wang B, Zheng Y, Kang H, He A, Zhao L Genes Dis. 2025; 12(3):101307.

PMID: 40028036 PMC: 11870172. DOI: 10.1016/j.gendis.2024.101307.

Mechanism of histone demethylase KDM5A in osteoporotic fracture healing through epigenetic regulation of the miR-495/SKP2/Runx2 axis.

Li Z, Zhang J, Xu T, Hao Z, Li Y Mol Med. 2025; 31(1):65.

PMID: 39972431 PMC: 11837617. DOI: 10.1186/s10020-025-01098-5.

Lysine specific demethylase 1 conditional myeloid cell knockout mice have decreased osteoclast differentiation due to increased IFN- gene expression.

Astleford-Hopper K, Abrahante Llorens J, Bradley E, Mansky K JBMR Plus. 2024; 9(1):ziae142.

PMID: 39664933 PMC: 11632826. DOI: 10.1093/jbmrpl/ziae142.

Exploring epigenetic strategies for the treatment of osteoporosis.

Yi S, Lim J, Kim K Mol Biol Rep. 2024; 51(1):398.

PMID: 38453825 DOI: 10.1007/s11033-024-09353-4.

Histone demethylase KDM7A regulates bone homeostasis through balancing osteoblast and osteoclast differentiation.

Shan L, Yang X, Liao X, Yang Z, Zhou J, Li X Cell Death Dis. 2024; 15(2):136.

PMID: 38346941 PMC: 10861515. DOI: 10.1038/s41419-024-06521-z.

References

Chen J, Tu X, Esen E, Joeng K, Lin C, Arbeit J . WNT7B promotes bone formation in part through mTORC1. PLoS Genet. 2014; 10(1):e1004145. PMC: 3907335. DOI: 10.1371/journal.pgen.1004145. View

Long F . Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2011; 13(1):27-38. DOI: 10.1038/nrm3254. View

Wang J, Hevi S, Kurash J, Lei H, Gay F, Bajko J . The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet. 2008; 41(1):125-9. DOI: 10.1038/ng.268. View

Tu X, Delgado-Calle J, Condon K, Maycas M, Zhang H, Carlesso N . Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone. Proc Natl Acad Sci U S A. 2015; 112(5):E478-86. PMC: 4321271. DOI: 10.1073/pnas.1409857112. View

Logan M, Martin J, Nagy A, Lobe C, Olson E, Tabin C . Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis. 2002; 33(2):77-80. DOI: 10.1002/gene.10092. View

Huang Z, Ren P, Ma T, Smith R, Goodman S . Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine. 2010; 51(3):305-10. DOI: 10.1016/j.cyto.2010.06.002. View

Seemann P, Schwappacher R, Kjaer K, Krakow D, Lehmann K, Dawson K . Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest. 2005; 115(9):2373-81. PMC: 1190374. DOI: 10.1172/JCI25118. View

Mohammad H, Smitheman K, Kamat C, Soong D, Federowicz K, Van Aller G . A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. Cancer Cell. 2015; 28(1):57-69. DOI: 10.1016/j.ccell.2015.06.002. View

Takeuchi M, Fuse Y, Watanabe M, Andrea C, Takeuchi M, Nakajima H . LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2. Proc Natl Acad Sci U S A. 2015; 112(45):13922-7. PMC: 4653156. DOI: 10.1073/pnas.1517326112. View

10.

Zou W, Greenblatt M, Brady N, Lotinun S, Zhai B, de Rivera H . The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2. J Exp Med. 2013; 210(9):1793-806. PMC: 3754873. DOI: 10.1084/jem.20111790. View

11.

Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013; 19(2):179-92. DOI: 10.1038/nm.3074. View

12.

Wang L, Jin Q, Lee J, Su I, Ge K . Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc Natl Acad Sci U S A. 2010; 107(16):7317-22. PMC: 2867706. DOI: 10.1073/pnas.1000031107. View

13.

Lv L, Ge W, Liu Y, Lai G, Liu H, Li W . Lysine-specific demethylase 1 inhibitor rescues the osteogenic ability of mesenchymal stem cells under osteoporotic conditions by modulating H3K4 methylation. Bone Res. 2017; 4:16037. PMC: 5192052. DOI: 10.1038/boneres.2016.37. View

14.

Hojfeldt J, Agger K, Helin K . Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov. 2013; 12(12):917-30. DOI: 10.1038/nrd4154. View

15.

Chen W, Baylink D, Brier-Jones J, Neises A, Kiroyan J, Rundle C . PDGFB-based stem cell gene therapy increases bone strength in the mouse. Proc Natl Acad Sci U S A. 2015; 112(29):E3893-900. PMC: 4517286. DOI: 10.1073/pnas.1501759112. View

16.

Miclea R, Karperien M, Bosch C, van der Horst G, van der Valk M, Kobayashi T . Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev Biol. 2009; 9:26. PMC: 2678105. DOI: 10.1186/1471-213X-9-26. View

17.

Bennett C, Ouyang H, Ma Y, Zeng Q, Gerin I, Sousa K . Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res. 2007; 22(12):1924-32. DOI: 10.1359/jbmr.070810. View

18.

Zaidi M . Skeletal remodeling in health and disease. Nat Med. 2007; 13(7):791-801. DOI: 10.1038/nm1593. View

19.

Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine G . Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature. 2007; 446(7138):882-7. DOI: 10.1038/nature05671. View

20.

Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N . Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell. 2001; 103(7):1085-97. DOI: 10.1016/s0092-8674(00)00211-7. View